Broadwood Capital’s Serina Therapeutics SER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $525K | Hold |
85,219
| – | – | 0.03% | 8 |
|
|
2025
Q1 | $483K | Hold |
85,219
| – | – | 0.04% | 8 |
|
|
2024
Q4 | $427K | Hold |
85,219
| – | – | 0.03% | 7 |
|
|
2024
Q3 | $570K | Hold |
85,219
| – | – | 0.04% | 7 |
|
|
2024
Q2 | $816K | Hold |
85,219
| – | – | 0.06% | 7 |
|
|
2024
Q1 | $1.15M | Hold |
85,219
| – | – | 0.09% | 7 |
|
|
2023
Q4 | $1.15M | Hold |
85,219
| – | – | 0.1% | 7 |
|
|
2023
Q3 | $2.04M | Hold |
85,219
| – | – | 0.18% | 7 |
|
|
2023
Q2 | $2.68M | Hold |
85,219
| – | – | 0.2% | 7 |
|
|
2023
Q1 | $1.99M | Hold |
85,219
| – | – | 0.14% | 7 |
|
|
2022
Q4 | $1.65M | Hold |
85,219
| – | – | 0.14% | 7 |
|
|
2022
Q3 | $1.68M | Hold |
85,219
| – | – | 0.13% | 8 |
|
|
2022
Q2 | $1.73M | Hold |
85,219
| – | – | 0.13% | 8 |
|
|
2022
Q1 | $2.56M | Hold |
85,219
| – | – | 0.18% | 7 |
|
|
2021
Q4 | $3.27M | Hold |
85,219
| – | – | 0.2% | 7 |
|
|
2021
Q3 | $2.82M | Hold |
85,219
| – | – | 0.14% | 7 |
|
|
2021
Q2 | $4.65M | Hold |
85,219
| – | – | 0.21% | 7 |
|
|
2021
Q1 | $4.86M | Hold |
85,219
| – | – | 0.26% | 7 |
|
|
2020
Q4 | $4.56M | Hold |
85,219
| – | – | 0.27% | 7 |
|
|
2020
Q3 | $2.43M | Hold |
85,219
| – | – | 0.19% | 7 |
|
|
2020
Q2 | $2.84M | Hold |
85,219
| – | – | 0.22% | 7 |
|
|
2020
Q1 | $2.79M | Hold |
85,219
| – | – | 0.33% | 7 |
|
|
2019
Q4 | $5.46M | Hold |
85,219
| – | – | 0.63% | 7 |
|
|
2019
Q3 | $5.87M | Hold |
85,219
| – | – | 0.82% | 7 |
|
|
2019
Q2 | $11M | Hold |
85,219
| – | – | 1.38% | 7 |
|
|
2019
Q1 | $12.1M | Hold |
85,219
| – | – | 1.49% | 7 |
|
|
2018
Q4 | $8.96M | Buy |
+85,219
| New | +$8.96M | 1.26% | 7 |
|